PT1771421E - Derivados de n-hidroxiamida e sua utilização - Google Patents
Derivados de n-hidroxiamida e sua utilização Download PDFInfo
- Publication number
- PT1771421E PT1771421E PT05772035T PT05772035T PT1771421E PT 1771421 E PT1771421 E PT 1771421E PT 05772035 T PT05772035 T PT 05772035T PT 05772035 T PT05772035 T PT 05772035T PT 1771421 E PT1771421 E PT 1771421E
- Authority
- PT
- Portugal
- Prior art keywords
- hydroxyamide derivatives
- hydroxyamide
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59111104P | 2004-07-26 | 2004-07-26 | |
EP04103574 | 2004-07-26 | ||
EP05100641 | 2005-01-31 | ||
US64892405P | 2005-02-01 | 2005-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1771421E true PT1771421E (pt) | 2009-05-25 |
Family
ID=39243755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT05772035T PT1771421E (pt) | 2004-07-26 | 2005-07-25 | Derivados de n-hidroxiamida e sua utilização |
Country Status (24)
Country | Link |
---|---|
US (2) | US8008302B2 (pt) |
EP (1) | EP1771421B1 (pt) |
JP (1) | JP5226307B2 (pt) |
KR (1) | KR20070046873A (pt) |
CN (1) | CN1989106B (pt) |
AR (1) | AR050435A1 (pt) |
AT (1) | ATE430133T1 (pt) |
AU (1) | AU2005266313B2 (pt) |
BR (1) | BRPI0513878A (pt) |
CA (1) | CA2570903C (pt) |
CY (1) | CY1109194T1 (pt) |
DE (1) | DE602005014236D1 (pt) |
DK (1) | DK1771421T3 (pt) |
EA (1) | EA012584B1 (pt) |
ES (1) | ES2325836T3 (pt) |
HR (1) | HRP20090360T1 (pt) |
IL (1) | IL180682A (pt) |
MX (1) | MX2007001022A (pt) |
NO (1) | NO20070994L (pt) |
PL (1) | PL1771421T3 (pt) |
PT (1) | PT1771421E (pt) |
RS (1) | RS50980B (pt) |
SI (1) | SI1771421T1 (pt) |
WO (1) | WO2006010751A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060037446A (ko) * | 2003-08-23 | 2006-05-03 | 베르날리스(옥스포드)엘티디 | 금속 단백질 분해효소로서의 히드록삼산 유도체 |
CN101208320B (zh) | 2005-01-31 | 2012-01-11 | 默克雪兰诺有限公司 | N-羟基酰胺衍生物及其用途 |
CA2822776A1 (en) | 2006-10-28 | 2008-05-08 | Methylgene Inc. | Inhibitors of histone deacetylase |
WO2008079945A2 (en) * | 2006-12-20 | 2008-07-03 | University Of South Florida | Rock inhibitors and uses thereof |
JO2959B1 (en) * | 2007-05-14 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Mono-hydrochloric salts for histone dacetylase inhibitor |
WO2017041228A1 (zh) * | 2015-09-08 | 2017-03-16 | 浙江九洲药业股份有限公司 | 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法 |
EP3529245A4 (en) * | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
WO2019018795A1 (en) * | 2017-07-20 | 2019-01-24 | Yumanity Therapeutics | COMPOUNDS AND USES THEREOF |
US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
US11505547B2 (en) | 2017-11-30 | 2022-11-22 | Step Pharma S.A.S. | Compounds |
US11655246B2 (en) | 2017-11-30 | 2023-05-23 | Step Pharma S.A.S. | Aminothiazole compounds as inhibitors of CTPS1 |
EP3492454A1 (en) * | 2017-11-30 | 2019-06-05 | Step Pharma S.A.S. | Compounds |
WO2019209962A1 (en) | 2018-04-25 | 2019-10-31 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
WO2019241131A1 (en) | 2018-06-11 | 2019-12-19 | Pipeline Therapeutics, Inc. | Muscarinic acetylcholine m1 receptor antagonists |
MX2021004659A (es) | 2018-10-23 | 2021-05-28 | Step Pharma S A S | Derivados de aminopirimidina/pirazina como inhibidores de ctps1. |
CA3156666A1 (en) * | 2019-10-07 | 2021-04-15 | Pipeline Therapeutics, Inc. | MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS |
US11752149B2 (en) | 2019-12-02 | 2023-09-12 | Pipeline Therapeutics, Inc. | Muscarinic acetylcholine M1 receptor antagonists |
CN115780487B (zh) * | 2023-01-05 | 2023-05-05 | 河北东丽新材料有限公司 | 一种萃取剂及利用其处理4,4`-联苯醚二酐生产固废的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9215665D0 (en) | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
WO1995029892A1 (en) * | 1994-04-28 | 1995-11-09 | The Du Pont Merck Pharmaceutical Company | Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents |
GB9411598D0 (en) * | 1994-06-09 | 1994-08-03 | Hoffmann La Roche | Hydroxamic acid derivatives |
GB9702088D0 (en) | 1997-01-31 | 1997-03-19 | Pharmacia & Upjohn Spa | Matrix metalloproteinase inhibitors |
US6797820B2 (en) * | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
WO2001083461A1 (fr) | 2000-04-28 | 2001-11-08 | Shionogi & Co., Ltd. | Derives de thiazole et d'oxazole |
GB0208176D0 (en) * | 2002-04-09 | 2002-05-22 | Novartis Ag | Organic compounds |
KR20060037446A (ko) * | 2003-08-23 | 2006-05-03 | 베르날리스(옥스포드)엘티디 | 금속 단백질 분해효소로서의 히드록삼산 유도체 |
-
2005
- 2005-07-25 PL PL05772035T patent/PL1771421T3/pl unknown
- 2005-07-25 BR BRPI0513878-7A patent/BRPI0513878A/pt not_active IP Right Cessation
- 2005-07-25 KR KR1020077004004A patent/KR20070046873A/ko active IP Right Grant
- 2005-07-25 CN CN2005800250862A patent/CN1989106B/zh not_active Expired - Fee Related
- 2005-07-25 JP JP2007523074A patent/JP5226307B2/ja not_active Expired - Fee Related
- 2005-07-25 SI SI200530725T patent/SI1771421T1/sl unknown
- 2005-07-25 WO PCT/EP2005/053616 patent/WO2006010751A1/en active Application Filing
- 2005-07-25 DE DE602005014236T patent/DE602005014236D1/de active Active
- 2005-07-25 RS RSP-2009/0316A patent/RS50980B/sr unknown
- 2005-07-25 ES ES05772035T patent/ES2325836T3/es active Active
- 2005-07-25 MX MX2007001022A patent/MX2007001022A/es active IP Right Grant
- 2005-07-25 US US11/572,761 patent/US8008302B2/en not_active Expired - Fee Related
- 2005-07-25 AU AU2005266313A patent/AU2005266313B2/en not_active Ceased
- 2005-07-25 EA EA200700037A patent/EA012584B1/ru not_active IP Right Cessation
- 2005-07-25 EP EP05772035A patent/EP1771421B1/en active Active
- 2005-07-25 DK DK05772035T patent/DK1771421T3/da active
- 2005-07-25 PT PT05772035T patent/PT1771421E/pt unknown
- 2005-07-25 CA CA2570903A patent/CA2570903C/en not_active Expired - Fee Related
- 2005-07-25 AT AT05772035T patent/ATE430133T1/de active
- 2005-07-26 AR ARP050103093A patent/AR050435A1/es not_active Application Discontinuation
-
2007
- 2007-01-11 IL IL180682A patent/IL180682A/en not_active IP Right Cessation
- 2007-02-21 NO NO20070994A patent/NO20070994L/no not_active Application Discontinuation
-
2009
- 2009-06-23 HR HR20090360T patent/HRP20090360T1/hr unknown
- 2009-06-30 CY CY20091100695T patent/CY1109194T1/el unknown
-
2011
- 2011-06-08 US US13/155,411 patent/US8247437B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US8247437B2 (en) | 2012-08-21 |
CY1109194T1 (el) | 2014-07-02 |
AU2005266313A1 (en) | 2006-02-02 |
ATE430133T1 (de) | 2009-05-15 |
US8008302B2 (en) | 2011-08-30 |
IL180682A (en) | 2011-11-30 |
DK1771421T3 (da) | 2009-07-13 |
WO2006010751A1 (en) | 2006-02-02 |
EP1771421B1 (en) | 2009-04-29 |
RS50980B (sr) | 2010-10-31 |
EA200700037A1 (ru) | 2007-08-31 |
PL1771421T3 (pl) | 2009-08-31 |
NO20070994L (no) | 2007-04-26 |
BRPI0513878A (pt) | 2008-05-20 |
MX2007001022A (es) | 2007-04-12 |
HRP20090360T1 (hr) | 2009-08-31 |
IL180682A0 (en) | 2007-06-03 |
CA2570903A1 (en) | 2006-02-02 |
CA2570903C (en) | 2013-09-17 |
ES2325836T3 (es) | 2009-09-21 |
CN1989106B (zh) | 2013-12-04 |
EA012584B1 (ru) | 2009-10-30 |
AR050435A1 (es) | 2006-10-25 |
US20110263628A1 (en) | 2011-10-27 |
CN1989106A (zh) | 2007-06-27 |
JP5226307B2 (ja) | 2013-07-03 |
KR20070046873A (ko) | 2007-05-03 |
EP1771421A1 (en) | 2007-04-11 |
JP2008507575A (ja) | 2008-03-13 |
US20080021028A1 (en) | 2008-01-24 |
DE602005014236D1 (de) | 2009-06-10 |
AU2005266313B2 (en) | 2011-08-25 |
SI1771421T1 (sl) | 2009-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1771421T1 (sl) | Derivati n-hidroksiamida in njihova uporaba | |
EP1731506A4 (en) | 5-HYDROXYINDOL-3-CARBOXYLATE DERIVATIVES AND THEIR USE | |
HK1101911A1 (en) | Tetrahydrocarbozoles and derivatives | |
IL179640A0 (en) | Metastin derivatives and use thereof | |
EP1766616A4 (en) | EQUIPMENT AND EQUIPMENT ARRANGEMENTS | |
ZA200701820B (en) | Substituted phenylaminothiazoles and use thereof | |
EP1802588A4 (en) | SUBSTITUTED AMINOPYRIMIDONE AND APPLICATIONS THEREOF | |
IL179497A0 (en) | Carboranylporphyrins and uses thereof | |
EP1737458A4 (en) | R (-) - 11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF | |
IL178888A0 (en) | Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives | |
EP1737565A4 (en) | COS CLAUS CONFIGURATIONS AND METHODS | |
IL184008A0 (en) | 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments | |
IL180365A0 (en) | Carboranylporphyrins and uses thereof | |
EP1810976A4 (en) | BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND THE USE THEREOF | |
PL1951687T3 (pl) | Pochodne N-hydroksyamidu i ich zastosowanie | |
ZA200704650B (en) | 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments | |
ZA200700744B (en) | N-Hydroxyamide derivatives and use thereof | |
ZA200610820B (en) | Metastin derivatives and use thereof | |
SI1951687T1 (sl) | N-hidroksiamidni derivati in uporaba le-teh | |
GB0427723D0 (en) | Compounds and their use | |
IL165458A0 (en) | And | |
EP1759703A4 (en) | IMMUNOSTIMULATING AGENT AND INTERF ROGEN | |
EP1732545A4 (en) | TETRAHYDRO-BETA-CARBOLINE COMPOUNDS AND USE THEREOF | |
GB0423234D0 (en) | Compounds and their use | |
GB0405304D0 (en) | Compounds and their use |